Quality of life after brachytherapy in patients with glioblastoma multiforme

European Journal of Cancer

Volumn 40, Issue 7, 2004, Pages 1013-1020

  Koot, R W ^a   De Heer, K ^a   Oort, F J ^a   Hulshof, M C C M ^a   Bosch, D A ^a   De Haes, J C J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Brachytherapy; Glioblastoma multiforme; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; CORRELATION ANALYSIS; FOLLOW UP; GLIOBLASTOMA; HUMAN; LONG TERM CARE; MEASUREMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SYMPTOM; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANALYSIS OF VARIANCE; BRACHYTHERAPY; CAREGIVERS; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; STRESS, PSYCHOLOGICAL;

EID: 1942453266     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.01.018     Document Type: Article

References (28)

1. Laperriere N.J., Leung P.M., McKenzie S.et al. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int. J. Radiat. Oncol. Biol. Phys. 41:1998;1005-1011.
2. Selker R.G., Shapiro W.R., Burger P.et al. The Brain Tumor Cooperative Group NIH Trial 87-01. a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, intersitial radiotherapy boost, external radiation therapy, and carmustine Neurosurgery. 51:2002;343-355. discussion 355-357.
3. Koot R.W., Maarouf M., Hulshof M.C.et al. Brachytherapy. results of two different therapy strategies for patients with primary glioblastoma multiforme Cancer. 88:2000;2796-2802.
4. de Haes J.C.J.M., Olschewski M., Fayers P.et al. Measuring the quality of life of cancer patients with the Rotterdam Symptom Checklist (RSCL), a manual. 1996;Northern Centre for Healthcare Research, Groningen, The Netherlands.
5. Karnofsky D.A., Burchenal J.H. The clinical evaluation of chemotherapeutic agents in cancer. MacLeod C.M. Evaluation of Chemotherapeutic Agents. 1949;191-205 Colombia University Press, New York.
6. Lezak M.D. Neuropsychological Assessment. 1995;Academic Press, New York.
7. Mahoney F.I., Barthel D.W. Barthel activities of daily living index. Md. State Med. J. 14:1965;61-66.
8. Nunnally J.C. Psychometric Theory. 1978;McGraw Hill, New York.
9. Taphoorn M.J., Schiphorst A.K., Snoek F.J.et al. Cognitive functions and quality of life in patients with low-grade gliomas. the impact of radiotherapy Ann. Neurol. 36:1994;48-54.
10. Archibald Y.M., Lunn D., Cairncross J.G. Cognitive functioning in long-term survivors of high grade glioma. J. Neurosurg. 80:1994;247-253.
11. Giovagnoli A.R., Tamburini M., Boiardi A. Quality of life in brain tumor patients. J. Neurooncol. 30:1996;71-80.
12. Kiebert G.M., Curran D., Aaronson N.K.et al. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult. results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group Eur. J. Cancer. 34:1998;1902-1909.
13. Taphoorn M.J., Heimans J.J., Snoek F.J.et al. Assessment of quality of life in patients treated for low-grade glioma. a preliminary report J. Neurol. Neurosurg. Psychiatry. 55:1992;372-376.
14. Meyers C.A., Hess K.R., Yung W.K., Levin V.A. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J. Clin. Oncol. 18:2000;646-650.
15. Choucair A.K., Scott C., Urtasun R., Nelson D., Mousas B., Curran W. Quality of life and neuropsychological evaluation for patients with malignant astrocytomas. RTOG 91-14. Radiation Therapy Oncology Group Int. J. Radiat. Oncol. Biol. Phys. 38:1997;9-20.
16. Jason G.W., Pajurkova E.M., Taenzer P.A., Bultz B.D. Acute effects on neuropsychological function and quality of life by high-dose multiple daily fractionated radiotherapy for malignant astrocytomas. assessing the tolerability of a new radiotherapy regimen Psychooncology. 6:1997;151-157.
17. Weitzner M.A., Meyers C.A., Byrne K. Psychosocial functioning and quality of life in patients with primary brain tumors. J. Neurosurg. 84:1996;29-34.
18. Weitzner M.A., Meyers C.A., Gelke C.K., Byrne K.S., Cella D.F., Levin V.A. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumours. Cancer. 75:1995;1151-1161.
19. Lyons G.J. The 'PRESTON Profile' - the first disease-specific tool for assessing quality of life in patients with malignant glioma. Disabil. Rehabil. 18:1996;460-468.
20. Osoba D., Aaronson N.K., Muller M.et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual. Life Res. 5:1996;139-150.
21. Osoba D., Aaronson N.K., Muller M.et al. Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma. J. Neurooncol. 34:1997;263-278.
22. Bampoe J., Laperriere N., Pintilie M., Glen J., Micallef J., Bernstein M. Quality of life in patients with glioblastoma multiforme participating in a randomized study of brachytherapy as a boost treatment. J. Neurosurg. 93:2000;917-926.
23. Sneeuw K.C., Sprangers M.A., Aaronson N.K. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J. Clin. Epidemiol. 55:2002;1130-1143.
24. Guyatt G.H., Feeny D.H., Patrick D.L. Measuring health-related quality of life. Ann. Intern. Med. 118:1993;622-629.
25. Mackworth N., Fobair P., Prados M.D. Quality of life self-reports from 200 brain tumour patients. comparisons with Karnofsky performance scores J. Neurooncol. 14:1992;243-253.
26. Hochberg F.H., Slotnick B. Neuropsychologic impairment in astrocytoma survivors. Neurology. 30:1980;172-177.
27. Maire J.P., Coudin B., Guerin J., Caudry M. Neuropsychologic impairment in adults with brain tumours. Am. J. Clin. Oncol. 10:1987;156-162.
28. Aiken R.D. Quality-of-life issues in patients with malignant gliomas. Semin. Oncol. 21:1994;273-275.